Primary Sjögren's syndrome (PSS)
Clinical trials for Primary Sjögren's syndrome (PSS) explained in plain language.
Never miss a new study
Get alerted when new Primary Sjögren's syndrome (PSS) trials appear
Sign up with your email to follow new studies for Primary Sjögren's syndrome (PSS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a Lab-Made antibody quiet the immune attack behind Sjögren's syndrome?
Disease control Not yet recruitingResearchers are testing an experimental antibody called JH013 in adults with primary Sjögren's syndrome, a condition where the immune system attacks moisture-producing glands and other tissues. The trial has two parts: one gives a single injection at increasing doses, and the oth…
Matched conditions: PRIMARY SJÖGREN'S SYNDROME (PSS)
Phase 1 • Sponsor: Biotech Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New Sjogren's drug enters first human tests
Disease control Not yet recruitingThis early-stage study tests a new injection called CM336 in 30 adults with active Sjogren's syndrome. The main goal is to check safety and how the body handles the drug. Researchers will also look for signs that it helps control the disease. This is a Phase 1 trial, so it's one …
Matched conditions: PRIMARY SJÖGREN'S SYNDROME (PSS)
Phase 1 • Sponsor: Keymed Biosciences Co.Ltd • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC